ReviewFuture oncology (London, England)2025

Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine.

Brian M Slomovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.